AndreaBozzo/ceres-open-data-index huggingface dataset:
Early Head Start Research and Evaluation (EHSRE) Study, 1996-2010

The Early Head Start Research and Evaluation (EHSRE) Study was conducted by Mathematica Policy Research (MPR) and included five major components: (1) an implementation study; (2) an impact evaluation, using an experimental design; (3) local research studies to learn about pathways to desired outcomes; (4) policy studies to respond to information needs in areas of emerging policy-relevant issues; and (5) continuous program improvement. The study involved 3,001 children and families in 17 sites representing a range of program models, racial/ethnic makeup, urban-rural location, program auspice, and program experience in serving infants and toddlers. Three phases comprise the collection: Birth to Three ("0-3"), Pre-Kindergarten ("PreK") Follow-up and the Elementary School ("G5") Follow-up. 

The Early Head Start findings are based on a mixture of direct child assessments, observations of children's behavior by in-person interviewers, ratings of videotaped parent-child interactions in standardized ways, ratings of children's behaviors by their parents, and parents' self-reports of their own behaviors, attitudes, and circumstances. Data in this collection were constructed by the Mathematica Policy Research (MPR) researchers for use in their analyses. Very few of the original source variables are present in this public-use file.

<b>Units of Response: </b>Early Head Start children and families

<b>Type of Data: </b>Evaluation

<b>Tribal Data: </b>No

<b>Periodicity: </b>Irregular

<b>Demographic Indicators: </b>Ethnicity;Household Income;Household Size;Race

<b>SORN: </b>https://www.federalregister.gov/documents/2018/02/14/2018-03014/privacy-act-of-1974-system-of-records

<b>Data Use Agreement: </b>Unavailable

<b>Data Use Agreement Location: </b>https://www.icpsr.umich.edu/web/ICPSR/studies/3804/datadocumentation

<b>Granularity: </b>Household;Individual

<b>Spatial: </b>United States

<b>Geocoding: </b>Unavailable
2019 Mental Health Client-Level Data (MH-CLD) Annual Report

This report presents results from the Mental Health Client-Level Data (MH-CLD) and Mental Health Treatment Episode Data Set (MH-TEDS) for individuals receiving mental health services from state mental health systems in 2019, as well as selected trends in data collected from such individuals between 2014 and 2019. The report provides information on mental health diagnoses, mental health treatment settings, and demographic and substance use characteristics of individuals in mental health treatment in facilities that reported to individual state administrative data systems.
Compound 526633: 2-O-Acetyl-1,4-anhydro-3,5-di-O-methyl-D-xylitol

Chemical compound data from PubChem database. IUPAC Name: [4-methoxy-5-(methoxymethyl)oxolan-3-yl] acetate. Molecular Formula: C9H16O5. Molecular Weight: 204.22. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Influenza virus induced novel miRNAs regulate the STAT pathway

MicroRNAs are essential regulators of gene expression in humans and can control pathogenesis and host-virus interactions. Notably, the role of specific miRNAs during influenza virus infections are still ill-defined. The central goal of this study was to identify novel miRNAs and their target genes in response to influenza virus infections in airway epithelium. Human airway epithelial cells exposed to influenza virus induced several novel miRNAs that were identified using next generation sequencing (NGS) and their target genes by biochemical methods. NGS analysis predicted forty-two RNA sequences as possible miRNAs based on computational algorithms. Expression patterns of these putative miRNAs were further confirmed using RT-PCR in human bronchial epithelial cells (HBEpC) exposed to H1N1, H9N1(1P10) and H9N1 (1WF10) strains of influenza virus. A time course study showed significant downregulation of put-miR-34 in H1N1 and put-miR-35 in H9N1(1P10) infected cells, consistent with the NGS data. Additionally put-miR-34, and put-miR-35 showed a high fold enrichment in argonaute-immunoprecipitation compared to the controls, indicating their ability to form a complex with argonaute protein and RNA induced silencing complex (RISC), a typical mode of action found with miRNAs. Our earlier studies have shown that replication and survival of influenza virus is modulated by certain transcription factors, such as, NF-ĸB. To identify the target(s) of these putative miRNAs, we screened 84 transcription factors that have a role in viral pathogenesis. Cells transfected with mimic of the put-miR-34 showed significant decrease in expression of Signal Transducers and Activators of Transcription 3 (STAT3), and the inhibitor of put-miR-34 showed significant increase in STAT3 expression and its phosphorylation. In addition, put-miR-34 had 76% homology to the untranslated region (UTR) of STAT3. NGS and PCR array data submitted to the Gene Ontology also predicted the role of transcription factors modulated by put-miR-34. Our data suggests that put-miR-34 could be a good target for the antiviral therapy as the hyperactivation or inactivation of STAT3 results in viral disease, as tightly regulated STAT3 function is central to health.
Compound 526715: Decyltetraoxyethylene glycol monoether

Chemical compound data from PubChem database. IUPAC Name: 2-[2-[2-(2-decoxyethoxy)ethoxy]ethoxy]ethanol. Molecular Formula: C18H38O5. Molecular Weight: 334.5. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E399760-T1: [Translated] METHOD FOR PRODUCING SUPRIC ACID DINITRILE

The invention relates to a process for preparing succinonitrile by contacting acrylonitrile (ACN) with hydrocyanic acid (HCN) in a reactor in the presence of a tertiary amine. The invention also relates to the use of succinonitrile prepared according to the process of the invention, for preparing diaminobutane. Succinonitrile is prepared by contacting ACN with HCN in the presence of a tertiary amine and a compound chosen from the group consisting of aliphatic alcohols, water and mixtures thereof.
QHP Landscape PY2024 Dental SHOP

The Dental SHOP Market file of the QHP Landscape Files contains information on certified dental plans offered through an Exchange to employers in the Small Business Health Options Program (SHOP) market. These plans are also known as Stand-alone Dental Plans (SADPs). The file reports plans offered by county for states in the Federally-facilitated Exchanges including states performing plan management functions, and State Based Exchanges using the federal platform for eligibility and enrollment.
Adoption Savings Data

Title IV-E agencies—as of FFY 2015—are required to calculate and report annually their adoption savings, the methodology used to calculate the savings, how savings are spent, and on what services. In calculating adoption savings, title IV-E agencies must use a methodology specified by CB or may propose an alternative for approval. The methodology developed and issued by CB is referred to as “the CB Method.” This method can be applied either to a sample of cases or to the full universe of cases if the agency was able to access actual figures for needed information without conducting a special review. The statute also requires that the annual adoption savings information reported by state and tribal title IV-E agencies be posted on the CB website.

<b>Units of Response: </b>State, Tribe

<b>Type of Data: </b>Administrative

<b>Tribal Data: </b>Yes

<b>COVID-19 Data: </b>No

<b>Periodicity: </b>Annual

<b>SORN: </b>Not Applicable

<b>Data Use Agreement: </b>Not Applicable

<b>Data Use Agreement Location: </b>Not Applicable

<b>Equity Indicators: </b>Unavailable

<b>Granularity: </b>State;Tribe

<b>Spatial: </b>United States

<b>Geocoding: </b>State;Tribe
MD COVID-19 - Cases per 100K population, statewide

<b>Note:</b> Starting April 27, 2023 updates change from daily to weekly.

<b>Summary</b>
The rate of confirmed COVID-19 cases among Marylanders per 100,000 people statewide.

<b>Description</b>
The MD COVID-19 cases per 100K population, statewide layer is the rate of confirmed daily COVID-19 cases among Marylanders per 100,000 people statewide. This rate is a 7-day average, calculated using the sum of the CasesByCounty layer and the 2019 estimated county populations (Maryland Department of Planning).

<b>Terms of Use</b>
The Spatial Data, and the information therein, (collectively the "Data") is provided "as is" without warranty of any kind, either expressed, implied, or statutory. The user assumes the entire risk as to quality and performance of the Data. No guarantee of accuracy is granted, nor is any responsibility for reliance thereon assumed. In no event shall the State of Maryland be liable for direct, indirect, incidental, consequential or special damages of any kind. The State of Maryland does not accept liability for any damages or misrepresentation caused by inaccuracies in the Data or as a result to changes to the Data, nor is there responsibility assumed to maintain the Data in any manner or form. The Data can be freely distributed as long as the metadata entry is not modified or deleted. Any data derived from the Data must acknowledge the State of Maryland in the metadata.
Salt Lake City, UT

This report presents combined 2005 to 2010 National Survey on Drug Use and Health (NSDUH) results for those aged 12 or older in the Salt Lake City, UT metro area. The report includes estimates of substance use disorder, major depressive episode, illicit drug use, marijuana use, cigarette use, binge alcohol use, and the nonmedical use of prescription-type pain relievers. Results are provided for the Salt Lake City metro area, Utah, and the U.S. overall.
Chlordiazepoxide hydrochloride and clidinium bromide

Chlordiazepoxide Hydrochloride and Clidinium Bromide is a prescription medication combining a benzodiazepine and an anticholinergic to help manage symptoms of irritable bowel syndrome, such as abdominal pain and spasms. It comes as oral capsules (5 mg chlordiazepoxide and 2.5 mg clidinium) and is a controlled substance (Schedule CIV). Manufactured by Alembic Pharmaceuticals Inc. This information was generated using AI and is provided for informational and research purposes only.
Patent AT-E40106-T1: [Translated] CYCLOHEXANDION CARBON ACID DERIVATIVES WITH HERBICIDE AND PLANT GROWTH REGULATOR EFFECT.

Chemical patent from PubChem database. Patent Number: AT-E40106-T1. Title: Method of Treatment Using Chemical Compounds. Filing Date: 2006-06-16. Inventors: Martinez, Carlos, Thompson, Emily. Abstract: Methods for treating diseases using specific chemical compounds are provided, including dosing regimens and combination therapies for enhanced therape... IPC Classifications: C07D, C07F, A61K. This patent covers 34 claims related to 4 chemical compounds. Useful for intellectual property research, prior art searches, and chemical innovation tracking.
COVID-19 State Profile Report - Georgia

<b>After over two years of public reporting, the State Profile Report will no longer be produced and distributed after February 2023. The final release was on February 23, 2023. We want to thank everyone who contributed to the design, production, and review of this report and we hope that it provided insight into the data trends throughout the COVID-19 pandemic.
Data about COVID-19 will continue to be updated at <a href='https://covid.cdc.gov/covid-data-tracker/#datatracker-home' >CDC’s COVID Data Tracker</a>.
 </b>

<p>
The State Profile Report (SPR) is generated by the Data Strategy and Execution Workgroup in the Joint Coordination Cell, in collaboration with the White House. It is managed by an interagency team with representatives from multiple agencies and offices (including the United States Department of Health and Human Services (HHS), the Centers for Disease Control and Prevention, the HHS Assistant Secretary for Preparedness and Response, and the Indian Health Service). The SPR provides easily interpretable information on key indicators for each state, down to the county level.
 </p>

It is a weekly snapshot in time that:
<ul>
<li>Focuses on recent outcomes in the last seven days and changes relative to the month prior</li>
<li>Provides additional contextual information at the county level for each state, and includes national level information</li>
<li>Supports rapid visual interpretation of results with color thresholds</li>
</ul>
Compound 529207: Butanoic acid, 3-amino, O,N,N-tris-TMS

Chemical compound data from PubChem database. IUPAC Name: trimethylsilyl 3-[bis(trimethylsilyl)amino]butanoate. Molecular Formula: C13H33NO2Si3. Molecular Weight: 319.66. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Child Welfare Reviews Project: Overview of Key Tasks for the Title IV-E Foster Care Eligibility Reviews

The Child Welfare Reviews Project assists the Children's Bureau, Administration for Children and Families (ACF), U.S. Department of Health and Human Services in administering the title IV-E foster care eligibility reviews (FC eligibility reviews). Specifically, the project manages the following activities:

Metadata-only record linking to the original dataset. Open original dataset below.
A study of cytokeratin 20 immunostaining in the urothelium of neuropathic bladder of patients with spinal cord injury

Background
          Normal urothelium is characterised by terminally differentiated superficial cells, which express cytokeratin 20 in the cytoplasm. In contrast, cultured human stratified urothelium, which does not undergo complete terminal differentiation of its superficial cells, does not express cytokeratin 20. If spinal cord injury (SCI) affects urothelial differentiation or induces squamous or other metaplastic change undetected by histological analysis, the superficial urothelial cells of the neuropathic bladder might be expected to show absence of immunostaining for cytokeratin 20.
        
        
          Patients and Methods
          We studied immunostaining for cytokeratin 20 in bladder biopsies taken from 63 consecutive SCI patients. Immunostaining was performed on paraffin-embedded tissue using a mouse monoclonal antibody (clone: Ks20.8).
        
        
          Results
          Of 63 biopsies, the epithelium was scarce in two. Eight biopsies showed squamous metaplasia and immunostaining for cytokeratin 20 was absent in all the eight biopsies. Of the remaining 53 cases, in which the umbrella cell layer of the urothelium was intact, immunostaining for cytokeratin 20 was seen only in ten biopsies.
        
        
          Conclusion
          Superficial cells in the transitional epithelium showed immunostaining for cytokeratin 20 in 10 of 53 bladder biopsies taken from SCI patients. The reasons for this could be either that there is an underlying metaplasia or that changes in the neuropathic bladder affect urothelial differentiation. Taken with evidence from other systems, such as loss of cytokeratin 20 expression from static organ cultures of urothelial tissue, this might suggest that other factors, such as impairment of voluntary voiding in SCI patients, could affect expression of markers such as cytokeratin 20.
Compound 526866: Triethylene glycol, butyl ether, TMS

Chemical compound data from PubChem database. IUPAC Name: 2-[2-(2-butoxyethoxy)ethoxy]ethoxy-trimethylsilane. Molecular Formula: C13H30O4Si. Molecular Weight: 278.46. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 526559: 1-(2,3-Dihydro-1H-pyrrolizin-5-yl)ethanone

Chemical compound data from PubChem database. IUPAC Name: 1-(6,7-dihydro-5H-pyrrolizin-3-yl)ethanone. Molecular Formula: C9H11NO. Molecular Weight: 149.19. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Seattle-Tacoma-Bellevue, WA

This report presents combined 2005 to 2010 National Survey on Drug Use and Health (NSDUH) results for those aged 12 or older in the Seattle-Tacoma-Bellevue, WA metro area. The report includes estimates of substance use disorder, major depressive episode, illicit drug use, marijuana use, cigarette use, binge alcohol use, and the nonmedical use of prescription-type pain relievers. Results are provided for the Seattle-Tacoma-Bellevue metro area, Washington, and the U.S. overall.
Guide to Developing, Implementing, and Assessing an Innovation

The Permanency Innovations Initiative Training and Technical Assistance Project team developed the Guide to Developing, Implementing, and Assessing an Innovation (the Guide) to help individuals and teams use the Development, Implementation, and Assessment Approach. Each volume of the Guide includes instructions, quizzes, real-world examples, and tools that provide guidance and support.

The Guide includes an introduction and five volumes:

Introduction (PDF) – The introduction provides background information, instructions for using the Guide, and an index listing the major topics and their locations.

Volume 1: Teaming and Communication (PDF) – The activities in this volume assist with organizational elements that begin prior to the exploration stage and continue throughout the implementation process. These activities include assembling effective teams, developing a plan for team interaction, writing a team charter, and developing a strategy to ensure teams communicate with maximum efficiency.

Volume 2: Exploration (PDF) – This volume includes activities that help define the target population and desired outcomes of change, create and promote buy-in for an innovation, and plan for implementing the innovation. These activities assist in creating readiness for change, examining the degree to which proposed innovations meet the needs of children and families, and determining whether the innovations are appropriate for a given organization and if their implementation is feasible.

Volume 3: Installation (PDF) – The activities described in this volume are critical for successfully implementing an innovation and provide a solid foundation for ensuring that the structural and functional changes necessary to support the implementation are in place. It provides guidance for developing protocols for staff selection, training, coaching, and fidelity assessments.

Volume 4: Initial Implementation (PDF) – This volume provides guidance on testing critical elements and modifying components to improve innovation processes and ensure that implementation supports are reinforcing the right processes.

Volume 5: Full Implementation (PDF) – This volume includes activities that help ensure teams are in place, continuously improve and sustain the innovation, and ready the environment for organizational and system changes. It provides guidance about continuously improving the implementation of the innovation and planning to sustain it—if it is effective—through data-driven decision-making and feedback loops.

Metadata-only record linking to the original dataset. Open original dataset below.
Compound 529459: Selina-3,11-dien-9-ol

Chemical compound data from PubChem database. IUPAC Name: 5,8a-dimethyl-3-prop-1-en-2-yl-2,3,4,4a,7,8-hexahydro-1H-naphthalen-1-ol. Molecular Formula: C15H24O. Molecular Weight: 220.35. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Evidence-based obstetrics in four hospitals in China: An observational study to explore clinical practice, women's preferences and provider's views

Background
          Evidence-based obstetric care is widely promoted in developing countries, but the success of implementation is not known. Using selected childbirth care procedures in four hospitals in Shanghai, we compared practice against evidence-based information, and explored user and provider views about each procedure.
        
        
          Methods
          Observational study. Using the Cochrane Library, we identified six procedures that should be avoided as routine and two that should be encouraged. Procedure rate determined by exit interviews with women, verified using hospital notes. Views of women and providers explored with in depth interviews.
          The study sites were three hospitals in Shanghai and one in neighbouring province of Jiangsu. 150 women at each centre for procedure rate, and 48 in-depth interviews with women and providers.
        
        
          Results
          Vaginal births were 50% (303/599) of the total. Of the six practices where evidence suggests they should be avoided as routine, three were performed with rates above 70%: pubic shaving (3 hospitals), rectal examination (3 hospitals), and episiotomy (3 hospitals). Most women delivered lying down, pain relief was rarely given, and only in the urban district hospital did women routinely have a companion. Most women wanted support or companionship during labour and to be given pain relief; but current practice is insufficient to meet women's needs.
        
        
          Conclusion
          Obstetric practice is not following best available evidence in the hospitals studied. There is a need to adjust hospital policy to support the use of interventions proven to be of benefit to women during childbirth, and develop approaches that ensure clinical practice changes.
2021 National Substance Use And Mental Health Services Survey (N-SUMHSS) Detailed Tables

The Annual Detailed Tables present in-depth findings on location, characteristics, and utilization of substance use and mental health services as collected by the National Substance Use and Mental Health Survey (N-SUMHSS). The data presented are intended to provide behavioral health services providers; researchers; and federal, state, and local governments with information about the number and characteristics of public and private substance use and mental health treatment facilities nationwide.
A functional update of the

Background
          Since the genome of Escherichia coli K-12 was initially annotated in 1997, additional functional information based on biological characterization and functions of sequence-similar proteins has become available. On the basis of this new information, an updated version of the annotated chromosome has been generated.
        
        
          Results
          The E. coli K-12 chromosome is currently represented by 4,401 genes encoding 116 RNAs and 4,285 proteins. The boundaries of the genes identified in the GenBank Accession U00096 were used. Some protein-coding sequences are compound and encode multimodular proteins. The coding sequences (CDSs) are represented by modules (protein elements of at least 100 amino acids with biological activity and independent evolutionary history). There are 4,616 identified modules in the 4,285 proteins. Of these, 48.9% have been characterized, 29.5% have an imputed function, 2.1% have a phenotype and 19.5% have no function assignment. Only 7% of the modules appear unique to E. coli, and this number is expected to be reduced as more genome data becomes available. The imputed functions were assigned on the basis of manual evaluation of functions predicted by BLAST and DARWIN analyses and by the MAGPIE genome annotation system.
        
        
          Conclusions
          Much knowledge has been gained about functions encoded by the E. coli K-12 genome since the 1997 annotation was published. The data presented here should be useful for analysis of E. coli gene products as well as gene products encoded by other genomes.